Related by context. All words. (Click for frequent words.) 80 REOLYSIN R 78 REOLYSIN 72 Panzem R NCD 71 Reolysin 71 alvespimycin 69 PXD# 69 Proxinium TM 68 docetaxel Taxotere R 68 phase IIa clinical 68 ELACYT 68 neratinib 68 OncoVEX GM CSF 68 ixabepilone 67 NP2 Enkephalin 67 bortezomib Velcade 67 CBLC# 67 Allovectin 7 ® 67 PEG SN# 67 PSMA ADC 67 mapatumumab 67 velafermin 67 ThermoDox R 67 Allovectin 7 67 lapatinib Tykerb 67 CA4P 67 pralatrexate 67 Phase IIb clinical trials 67 Neuradiab 66 enzastaurin 66 cediranib 66 eniluracil 66 AKT inhibitor 66 CR# vcMMAE 66 MAGE A3 ASCI 66 phase IIb clinical 66 HGS ETR2 66 cilengitide 66 Abiraterone acetate 66 KRN# 66 oral ridaforolimus 66 FOLOTYN ® 66 IL# PE#QQR 66 BrachySil 66 JAK inhibitor 66 OMP #M# 66 TELINTRA 66 OvaRex ® MAb 66 HuMax EGFr 66 mertansine 65 pertuzumab 65 INCB# [001] 65 Phase #b/#a 65 OncoVEX 65 Azedra 65 oral deforolimus 65 huC# DM4 65 PI3K/Akt pathway inhibitor 65 adecatumumab 65 Panzem R 65 YONDELIS 65 Chemophase 65 AQ4N 65 L BLP# 65 oral prodrug 65 Panzem 65 aflibercept 65 multicenter Phase II 65 Proellex TM 65 docetaxel Taxotere ® 65 Phase Ib 65 Ontak 65 TLK# 65 forodesine 65 BrachySil TM 65 Alocrest 65 HuLuc# 65 Cloretazine R VNP#M 65 Cloretazine R 65 romidepsin 65 Phase Ib clinical 64 lintuzumab 64 IMA# 64 trastuzumab DM1 64 Degarelix 64 EFAPROXYN 64 Imprime PGG 64 dacetuzumab 64 EOquin TM 64 Ceflatonin 64 subcutaneous formulation 64 sorafenib Nexavar 64 personalized immunotherapy 64 AEG# 64 trastuzumab DM1 T DM1 64 Zybrestat 64 HGS# 64 HGS ETR1 64 cancer immunotherapies 64 voreloxin 64 obatoclax 64 ProLindac 64 PKC# 64 GRN#L 64 Fodosine 64 LEP ETU 64 Cloretazine ® 64 AP# [003] 64 hormone LHRH antagonist 64 OvaRex R 64 trastuzumab Herceptin R 64 VEGF Trap 64 #I TM# 64 GRNVAC1 64 Elotuzumab 64 KNS # 64 Revlimid lenalidomide 64 Darinaparsin 64 Annamycin 64 Phase Ib II 64 Phase #b/#a clinical 64 Gliadel Wafer 64 bevacizumab Avastin ® 64 Cloretazine 64 Insegia 64 GAP #B# 64 class mGluR5 inhibitor 64 novel VDA molecule 64 Asentar 64 PDX pralatrexate 64 MyVax R 63 BRIM2 63 Panzem NCD 63 Vandetanib 63 Phase 1b trial 63 Omacetaxine 63 Mitoxantrone 63 hypoxia activated prodrug 63 axitinib 63 tezampanel 63 docetaxel chemotherapy 63 depsipeptide 63 DOS# 63 tanespimycin 63 MEK inhibitors 63 aflibercept VEGF Trap 63 farletuzumab 63 radiation sensitizer 63 evaluating satraplatin 63 Amplimexon 63 LBH# 63 ADVEXIN clinical 63 ASONEP 63 rituximab Rituxan 63 Tarceva TM 63 docetaxel Taxotere 63 incyclinide 63 sorafenib tablets 63 TACI Ig 63 Phase IIIb clinical 63 ganetespib 63 ALN TTR# 63 Atiprimod 63 ThermoDox 63 CINTREDEKIN BESUDOTOX 63 OvaRex 63 OXi# 63 elotuzumab 63 BNC# 63 PrevOnco 63 Onconase 63 phase IIb III 63 Azedra TM 63 CoFactor 63 deforolimus 63 GVAX ® 63 Golimumab 63 zalutumumab 63 intratumoural 63 Romidepsin 63 nab paclitaxel 63 motesanib 63 ZACTIMA 63 Tyrima 63 galiximab 63 phase Ib 63 Bezielle 63 PrevOnco ™ 63 celgosivir 63 Neuradiab TM 63 riociguat 63 olaparib 63 Jevtana 63 OHR/AVR# 63 MEK inhibitor RDEA# 63 Phase 2b clinical 63 TASKi3 63 Phase Ib clinical trials 63 evaluating tivozanib 63 subcutaneous SC 63 Aplidin 63 MOZOBIL 63 drug GAP #B# 63 thymalfasin 63 Aflibercept 63 isoform selective 63 MGd 63 liposomal formulation 62 tyrosine kinase inhibitor 62 ALN VSP 62 Dacogen injection 62 palifosfamide 62 investigational monoclonal antibody 62 PLK1 SNALP 62 HGS ETR1 mapatumumab 62 glufosfamide 62 Clolar ® 62 Vidaza azacitidine 62 metaglidasen 62 HER2 positive metastatic breast 62 NEUMUNE 62 targeted radiotherapeutic 62 ThermoDox ® 62 Allovectin 7 R 62 receptor tyrosine kinase inhibitor 62 metastatic colorectal 62 Archexin 62 Viprinex 62 Tectin TM 62 EOquin 62 Ketotransdel 62 bevacizumab Avastin 62 Exherin TM 62 Xanafide 62 IAP inhibitors 62 oral antiviral 62 BRAF inhibitor 62 indibulin 62 OPAXIO 62 ZK EPO 62 HuMax CD4 62 gemcitabine chemotherapy 62 BEMA TM Fentanyl 62 Targretin 62 T DM1 62 Perforomist ™ Inhalation Solution 62 Sym# 62 sapacitabine 62 IRX 2 62 GALNS 62 Deforolimus 62 afatinib 62 paclitaxel Taxol ® 62 NGX# 62 vaccines oncolytic virus 62 concurrent chemoradiation 62 immunotherapeutic agent 62 DPX Survivac 62 chemotherapeutic drug 62 Dacogen decitabine 62 demonstrated antitumor activity 62 Temsirolimus 62 Nexavar ® 62 vinorelbine tartrate 62 CEQ# 62 HCD# [002] 62 Genasense ® oblimersen 62 Nexavar sorafenib 62 Afatinib 62 5 fluorouracil leucovorin 62 acetonide FA 62 Vicinium TM 62 paclitaxel poliglumex 62 Gemzar ® 62 Lovaxin C 62 anticancer therapies 62 FOLOTYN 62 anticancer compound 62 phase IIa 62 Intravenous CP 62 Pralatrexate 62 SAR# [004] 62 fallopian tube cancers 62 histamine dihydrochloride 62 Factor VIIa 62 RSD# oral 62 Cotara 62 belinostat 62 OncoGel 62 IIa trial 62 Taxotere chemotherapy 62 SIR Spheres 62 Squalamine 62 NP2 62 capecitabine Xeloda R 62 amrubicin 62 CYT# potent vascular disrupting 62 TOCOSOL Camptothecin 62 phase IIb 62 radiolabeled TM# 62 valopicitabine 62 Fludara 62 luteinizing hormone releasing 62 Genasense ® 62 TNFerade 62 TELCYTA 62 picoplatin 62 Luteinizing Hormone Releasing Hormone 61 Intarcia 61 Aurora kinase inhibitor 61 Tarvacin TM 61 Onco TCS 61 lumiliximab 61 Cetrorelix 61 talactoferrin 61 ADVEXIN 61 IMGN# 61 BAY #-# 61 PEG Interferon lambda 61 registrational 61 volociximab 61 APOPTONE 61 Azixa 61 vorinostat 61 R#/MEM # 61 PNT# 61 fosbretabulin 61 StemEx R 61 Lenocta 61 LymphoStat B TM 61 antiangiogenic therapy 61 lesinurad 61 Virulizin ® 61 carboplatin paclitaxel 61 anticancer therapy 61 anti angiogenic agents 61 PEG PAL 61 omega interferon 61 Phase 1b clinical 61 refractory acute myeloid 61 custirsen 61 tesetaxel 61 Daclizumab 61 cetuximab Erbitux ® 61 Canvaxin 61 Phase Ib study 61 Curaxin 61 CD# monoclonal antibody 61 Corlux 61 ABRAXANE ® 61 Provecta 61 Davanat 61 R sorafenib tablets 61 relapsed multiple myeloma 61 Ixempra 61 torezolid phosphate 61 TBC# 61 goserelin 61 DCVax R 61 MEK inhibitor 61 AeroLEF TM 61 PNP inhibitor 61 refractory AML 61 veltuzumab 61 Amrubicin 61 Capesaris 61 DCVax ® Brain 61 sunitinib malate 61 mTOR inhibition 61 radiotherapeutic 61 anticancer agents 61 rhIGF-I/rhIGFBP-3 61 visilizumab 61 clevidipine 61 Ixabepilone 61 anticancer agent 61 erlotinib Tarceva ® 61 talabostat 61 relapsed refractory multiple myeloma 61 Advexin 61 Viramidine 61 EndoTAG TM -1 61 topical ophthalmic 61 generation purine nucleoside 61 Neupogen ® 61 AAG geldanamycin analog 61 ALN PCS 61 ISTODAX 61 Nanobody 61 cetuximab Erbitux 61 zanolimumab 61 Phase #b/#a trial 61 Guanilib 61 ToGA 61 gemcitabine Gemzar ® 61 combination REOLYSIN R 61 ATL# [001] 61 Phase IIb III 61 RhuDex ® 61 VNP#M 61 oral picoplatin 61 LEUKINE 61 entinostat 61 Revimmune 61 Neulasta ® 61 SNALP technology 61 vosaroxin 61 ara C 61 oral salmon calcitonin 61 LHRH antagonist 61 Pazopanib 61 Seliciclib 61 XL# XL# 61 adipiplon 61 vidofludimus 61 Personalized Immunotherapy 61 PRECISE trial 61 teduglutide 61 synthetic retinoid 61 pan HDAC inhibitor 61 vascular disrupting agent 61 ONCONASE R 61 tezampanel NGX# 61 reslizumab 61 Androxal TM 61 Vaxfectin TM 61 alfa 2a 61 Aurexis 61 Velcade bortezomib 61 XL# XL# XL# 61 maximally tolerated dose 61 novel peptide 61 Taxotere docetaxel 61 thalidomide Thalomid 61 UPLYSO 61 chemotherapeutic regimen 61 Exelixis compounds 61 SUTENT ® 61 Herceptin trastuzumab 61 pediatric malignancies 61 Urocidin 61 TRISENOX 61 HQK 61 blinatumomab 61 liposomal doxorubicin 61 Hsp# Inhibitor 61 intranasal delivery 60 cannabinor 60 IMC A# 60 FOLFOX6 chemotherapy regimen 60 proteasome inhibitor 60 IMC #B 60 paclitaxel Taxol R 60 Hedgehog Pathway Inhibitor 60 Trofex 60 BioNumerik 60 OncoVex 60 Folotyn 60 Anthim 60 Sapacitabine 60 Cotara ® 60 biliary tract cancer 60 TRAIL receptor antibodies 60 recurrent metastatic ovarian cancer 60 Alpharadin 60 MyVax ® 60 alkylating agent 60 eprotirome 60 Onrigin 60 tolevamer 60 MEND CABG II 60 Novolimus 60 refractory APL 60 Perifosine 60 RSD# 60 JAK2 inhibitor 60 MGCD# [001] 60 acyclovir Lauriad R 60 BLP# Liposome Vaccine 60 alemtuzumab MS 60 optimal dosing 60 IoGen 60 pain palliation 60 IMP# 60 ZOLINZA 60 BRAF inhibitors 60 doxorubicin Transdrug ® 60 Zerenex 60 ocrelizumab 60 Gleevec imatinib 60 peginesatide 60 Plenaxis TM 60 GTC recombinant human 60 Pertuzumab 60 Xeloda ® 60 adecatumumab MT# 60 Saforis 60 dose escalation Phase 60 cisplatin gemcitabine 60 OMNARIS HFA 60 Phase 1b clinical trials 60 angiogenesis inhibitor 60 TOCOSOL Paclitaxel 60 Phase 1b 60 Civacir 60 Tarvacin 60 Triapine R 60 investigational humanized monoclonal antibody 60 investigational therapies 60 TREANDA 60 taribavirin 60 Pemetrexed 60 antibody MAb 60 FavId 60 registrational trial 60 PDE4 inhibitor 60 LE DT 60 telomerase therapeutic 60 Myocet 60 drug conjugate 60 carmustine 60 RPL# 60 Methylnaltrexone 60 Litx 60 methylnaltrexone 60 Phase #/#a trial 60 Aeroquin 60 imetelstat 60 virus HCV protease inhibitor 60 GLP toxicology studies 60 Carfilzomib 60 selective immunoproteasome inhibitor 60 telaprevir VX 60 XL# [003] 60 tiuxetan 60 midstage clinical 60 Ophena 60 adjuvant colon cancer 60 EndoTAGTM 1 60 Topical Interferon Alpha 2b 60 Aviptadil 60 Zemplar Capsules 60 Tesetaxel 60 Tanespimycin 60 Tykerb lapatinib 60 MDV# 60 TORISEL 60 INSPIRE Trial Phase III 60 dose escalation clinical 60 Aclidinium 60 Pafuramidine 60 tranilast 60 rNAPc2 60 humanised monoclonal antibody 60 AzaSite Plus 60 noninfectious uveitis 60 GW# [003] 60 SinuNase TM 60 Taxotere R 60 ridaforolimus 60 ANYARA 60 lorvotuzumab mertansine 60 WX UK1 60 TG# [003] 60 nalbuphine ER 60 MGCD# [002] 60 metastatic GIST 60 APPRAISE 60 Immunotherapeutic 60 estramustine 60 Leukine 60 midstage trials 60 ponatinib 60 perifosine 60 Solazed TM 60 ADI PEG 60 aerosolized KL4 surfactant 60 recurrent malignant gliomas 60 Traficet EN 60 OMS#HP 60 Phase IIa clinical 60 omacetaxine 60 postoperative chemotherapy 60 brivaracetam 60 CTAP# Capsules 60 Pyridorin 60 PROCHYMAL 60 denileukin diftitox 60 TheraCIM h R3 60 ruxolitinib 60 ARIKACE 60 liposomal 60 investigational hepatitis C 60 HspE7 60 ACTEMRA TM 60 pomalidomide 60 Phase 2a 60 Hycamtin 60 midstage clinical trials 60 boosted protease inhibitor 60 corticosteroid dexamethasone 60 Curaxin CBLC# 60 recurrent glioblastoma 60 pegfilgrastim 60 SinuNase 60 huN# DM1 60 oxymorphone ER 60 ZYBRESTAT 60 Bortezomib 60 chemotherapy cisplatin 60 microtubule inhibitor 60 interferon gamma 1b 60 Marqibo TM 60 tubulin inhibitor 60 Icatibant 60 Urocidin TM 60 Phase 2a trial 60 bendamustine 60 PEGylated interferon 60 apaziquone 60 PEP# [003] 60 Liprostin 60 systemic anaplastic large 60 Fx #A 60 velafermin belinostat 60 Exelixis XL# 60 CRLX# 60 blinded randomized placebo controlled 60 pentostatin 60 Protexia R 60 DermaVir Patch 60 imexon 60 #D#C# 60 Bicifadine 60 trial evaluating PRX# 60 OMP #R# 60 SNT MC# 60 biotherapy 60 triphendiol 60 Leukine ® 60 PRT# 60 rhITF 59 NeoLipid R 59 NeuroSTAT ® 59 Ophena TM 59 cancer neuroendocrine tumor 59 Zenvia ™ 59 systemic RNAi therapeutic 59 bicifadine 59 temozolomide 59 efaproxiral 59 ZYBRESTAT fosbretabulin 59 cytokine refractory 59 paclitaxel carboplatin 59 Xerecept 59 Xeloda capecitabine 59 BrachySil ™ 59 histone deacetylase inhibitor 59 humanized anti 59 EVIZON TM squalamine lactate 59 Tamibarotene 59 BEXXAR 59 superficial bladder cancer 59 Glufosfamide 59 Phase IIB 59 TRO# 59 CCX# 59 pharmacokinetic PK study 59 5 FU leucovorin 59 Enzastaurin 59 GVAX Pancreas Vaccine 59 Phase III confirmatory 59 monoclonal antibody conjugated 59 tremelimumab 59 Maximum Tolerated Dose MTD 59 Hyphanox 59 CA9 SCAN 59 Apaziquone 59 Soliris TM eculizumab 59 decitabine 59 vandetanib 59 chemotherapeutics 59 ONTAK 59 PREOS 59 2 methoxyestradiol 59 Ceplene/IL-2 59 refractory prostate cancer 59 PhG alpha 1 59 Sandostatin LAR Depot 59 Combination REOLYSIN R 59 Oxaliplatin 59 refractory chronic lymphocytic 59 iniparib 59 orBec 59 MVA BN 59 multitargeted 59 RGB # 59 MAXY G# 59 RAV# 59 PRTX 59 MYDICAR ® 59 Pivotal Phase III 59 isavuconazole 59 paclitaxel Taxol 59 Cethrin R 59 octreotide acetate 59 Apoptone 59 ReN# 59 uric acid lowering 59 squalamine 59 Stimuvax R 59 Aryplase 59 HuMax TAC 59 AE# vaccine 59 Troxatyl 59 intravesical instillation 59 Mepact 59 hA# 59 therapeutic monoclonal antibody 59 Neuvenge 59 Voraxaze 59 otelixizumab 59 Taxotere ® 59 ASA# 59 mitomycin 59 Eligen ® Technology 59 Quinamed 59 ularitide 59 Theratope 59 MyVax 59 HSP# inhibitor 59 oral taxane 59 mocetinostat MGCD# 59 sodium thiosulfate STS 59 ENMD # 59 investigational immunotherapy 59 trastuzumab Herceptin ® 59 tesmilifene 59 Tarceva erlotinib 59 ADVEXIN p# therapy 59 antifolates 59 Teriflunomide 59 Aptivus ® 59 dirucotide 59 Cotara R 59 vismodegib 59 refractory indolent non 59 Rebif ® 59 TNF alpha inhibitor 59 ospemifene 59 orally administered inhibitor 59 ritonavir boosted danoprevir 59 chimeric monoclonal antibody 59 Arimoclomol 59 ONCASPAR 59 carboplatin 59 Plasmin 59 Amigal 59 alpha 2a 59 systemic ALCL 59 Erbitux cetuximab 59 oral mTOR inhibitor 59 gefitinib Iressa 59 refractory metastatic 59 sorafenib Nexavar ® 59 oral rivaroxaban 59 Prosaptide 59 Solazed 59 CD# antibody [001] 59 therapeutic regimens 59 anti CD3 antibody 59 selective modulator 59 Selective Electrochemical Tumor Ablation 59 teriflunomide 59 Preclinical studies suggest 59 tramiprosate Alzhemed TM 59 AZILECT ® 59 Anavex #-# 59 mitogen activated ERK kinase 59 liposome encapsulated 59 atacicept 59 Cardio Vascu Grow 59 BENLYSTA ® 59 pegylated interferon peg IFN 59 Muraglitazar 59 efficacy tolerability 59 assessing T DM1 59 phase IIb trial 59 Zevalin R Ibritumomab 59 nonclinical studies 59 ALN RSV# 59 eltrombopag 59 recurrent malignant glioma 59 Acapodene 59 taxotere 59 satraplatin 59 dextromethorphan quinidine 59 HepeX B TM 59 ulimorelin 59 refractory cutaneous T 59 preclinically 59 DAVANAT 59 EXPAREL ™ 59 ganaxolone 59 eligen 59 Zemiva TM 59 Cethrin 59 HDAC Inhibitor 59 standard chemotherapy regimen 59 pemetrexed Alimta 59 cetuximab Erbitux R 59 Surfaxin LS 59 PEGPH# 59 confirmatory Phase III 59 Xelox 59 GRN# 59 TheraSphere 59 viral kinetics 59 Onalta ™ 59 LibiGel ® 59 vernakalant hydrochloride 59 GVAX 59 dose escalation 59 Mipomersen 59 novel therapeutic antibodies 59 nucleoside analog 59 novel immunotherapeutic 59 GLPG# 59 PF # [002] 59 lenalidomide Revlimid R 59 solid tumors 59 cell lymphoma CTCL 59 antimetabolite 59 microwave hyperthermia 59 either acutely decompensated 59 Phase 1a clinical 59 subcutaneous methylnaltrexone 59 Pirfenidone 59 eritoran 59 vascular disrupting agents 59 Hepatocellular Carcinoma HCC 59 KIACTA ™ 59 MitoQ 59 immunotherapeutic vaccine 59 Phase IIb clinical 59 TTF Therapy 59 EndoTAG 59 MGN# 59 Budesonide MMX 59 IIa clinical trials 59 Telintra 59 dexpramipexole 59 Exherin 59 G#DT 59 dalbavancin 59 Cellegesic 59 TRISENOX ® 59 RCW breast cancer 59 Cannabinor 59 cysteamine bitartrate 59 CCR5 mAb 59 IgG1 monoclonal antibody 59 oral methylnaltrexone 59 Dapagliflozin 59 DermaVir 59 Silodosin 59 VitiGam 59 RLY# 59 atrasentan 59 regorafenib 59 synthetic siRNA 59 GMX# 59 Phase 2a clinical 59 phase Ib clinical 59 FASLODEX 59 Anturol TM 59 Xcellerated T Cells 59 Zingo TM 59 DAVANAT R 59 Resten NG 58 NPC 1C 58 TPI ASM8 58 cutaneous T cell 58 etanercept Enbrel 58 CVac 58 IV Busulfex 58 Synavive 58 bardoxolone 58 targeting PCSK9 58 Fludara ® 58 antiangiogenic agents 58 samalizumab 58 Kamada AAT 58 platelet inhibitor 58 ongoing Phase 1b 58 cytarabine 58 balsalazide tablet 58 pafuramidine maleate 58 Initiate Clinical Trial 58 Gemcitabine 58 gemcitabine 58 lintuzumab SGN 58 Apixaban 58 seliciclib CYC# 58 DEB# 58 AEGR 58 rALLy clinical trial 58 PRX # 58 Celator 58 immunotherapeutics 58 XmAb# 58 AMD# [003] 58 Fibrin Pad 58 low dose cytarabine 58 randomized Phase IIb 58 RG# [001] 58 HCV protease inhibitors 58 Diamyd ® 58 advanced carcinoid 58 LymphoStat B belimumab 58 AERx ® 58 RH1 58 Symadex 58 vinorelbine 58 Phase 2b kidney transplant 58 L DOS# 58 vinca alkaloid 58 Peginterferon alfa 2b 58 dexanabinol 58 dirucotide MBP# 58 TKM PLK1 58 telomerase inhibitor drug 58 initiated Phase Ib 58 hormone refractory metastatic prostate 58 recurrent NSCLC 58 oral treprostinil 58 refractory multiple myeloma 58 Hsp# inhibitor 58 Ereska 58 PD LID 58 sodium stibogluconate 58 Phase 2b trial 58 Chrysalin 58 Trofex TM 58 sd rxRNA 58 granisetron 58 chemotherapeutic drugs 58 gallium nitrate 58 Tekamlo 58 PHX# 58 Cleviprex TM clevidipine 58 SERMs 58 CRMD# 58 orally inhaled 58 DCVax R Brain 58 Listeria vaccine 58 Marqibo 58 Rezular 58 relapsed ovarian cancer 58 randomized Phase 58 pradefovir 58 SPRYCEL ® 58 placebo controlled Phase 58 metastatic colorectal carcinoma 58 Aliskiren 58 sapacitabine CYC# 58 relapsed MM 58 ® bortezomib 58 SEPET TM 58 Sudhir Agrawal D.Phil 58 StemEx 58 VAPRISOL 58 EP #R 58 inhibitor RG# 58 selective androgen receptor modulator 58 unique alkylating agent 58 Irinotecan 58 Triapine 58 ILLUMINATE 58 initiate Phase Ib 58 carbohydrate polymers 58 intravesical infusion therapy 58 ELOXATIN 58 GED aPC 58 multiple myeloma MM 58 idarubicin 58 telaprevir dosed 58 Zolinza 58 LHRH antagonists 58 Junovan 58 Safinamide 58 TEMODAL 58 SomatoKine 58 overactive bladder AA# 58 TLR agonists 58 novel anticancer 58 double blinded placebo 58 Zalypsis 58 Vectibix panitumumab 58 radiolabeled monoclonal antibody